SK Hynix Moves Closer to New York ADR Listing Amid AI Chip Boom 
Tesla and NatPower Partner on $5 Billion Battery Storage Expansion in Europe 
Bain Capital Nears Deal for Majority Stake in Volkswagen Marine Engine Unit Everllence 
FedEx Stock Drops After Weak 2026 Earnings Forecast Despite Strong Q4 Results 
Trip.com Shares Tumble After Q1 Profit Drops and Weak Revenue Growth Outlook 
Heineken Names JDE Peet’s CEO Rafael Oliveira as New Chief Executive 
SpaceX Stock Rebounds After Sharp Selloff, But Valuation Concerns Persist 
Nissan Halts Electric Qashqai Development Amid EV Market Challenges 
Alibaba Shares Fall After Anthropic Alleges Massive AI Model Distillation Campaign 
Anthropic AI Model Uncovers Vulnerabilities in Classified U.S. Government Systems During Security Test 
SK Hynix Targets $29.4 Billion Nasdaq Listing to Expand AI Chip Business 
Pelosi Discloses Major Intel and Uber Call Option Purchases Worth Up to $6 Million 
Meta Reportedly Developing ‘Arena’ Prediction Market App to Rival Polymarket and Kalshi 
Trump Orders DOJ Investigation Into Exxon, Chevron Over High Gas Prices 
Samsung and SK Hynix Shares Jump After Micron Earnings Boost AI Chip Optimism 
Ryan Cohen Rejects GameStop Pay Package, Prepares New eBay Acquisition Plan 
Cerebras Revenue Forecast Tops Expectations, but Margin Concerns Weigh on Stock 
PLEASANTON, Calif., Feb. 24, 2016 -- Natus Medical Incorporated (NASDAQ:BABY) today announced that Jonathan Kennedy, Sr. Vice-President and Chief Financial Officer will present at the Raymond James 37th Annual Institutional Investors Conference in Orlando, Florida. Mr. Kennedy is scheduled to present on Wednesday, March 9th at 8:40 a.m. Eastern Time (5:40 a.m. PT).
Investors may listen to a live webcast and view a copy of the slide presentation online via the “Investors” section of the Company’s web site at http://investor.natus.com. The recorded webcast will be accessible online for at least 30 days.
About Natus Medical
Natus is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment and neurological dysfunction.
Additional information about Natus Medical can be found at www.natus.com.
COMPANY CONTACT: Natus Medical Incorporated Jonathan A. Kennedy Sr. Vice President Finance and Chief Financial Officer (925) 223-6700 [email protected]
